| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | +49.6% |
| Cost of Revenue | $2.5M | +56.2% |
| Gross Profit | $1.1M | +36.8% |
| R&D Expense | $1.5M | +99.1% |
| SG&A Expense | $6.1M | +1.3% |
| Operating Income | -$6.5M | -8.5% |
| Pre-tax Income | -$5.3M | -2.0% |
| Income Tax | $0 | — |
| Net Income | -$5.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.0M | +146.9% |
| Accounts Receivable | $165K | -42.5% |
| Current Assets | $14.8M | +128.1% |
| Total Assets | $15.9M | +108.9% |
| Current Liabilities | $2.0M | -9.6% |
| Total Liabilities | $2.2M | -11.4% |
| Stockholders' Equity | $13.8M | +165.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.4M | -35.3% |
| Capital Expenditures | $39K | — |
| Investing Cash Flow | -$218K | -108.8% |
| Financing Cash Flow | $12.9M | — |
| Free Cash Flow | -$4.4M | — |
| -2.0% |
| EPS (Basic) | -$0.11 | +15.4% |
| EPS (Diluted) | -$0.11 | +15.4% |